<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20231109230959&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20231109230959&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Fri, 10 Nov 2023 04:10:00 +0000</lastbuilddate>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944164/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093/eurheartj/ehad672. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944164/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944164</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad672>10.1093/eurheartj/ehad672</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944164</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Nazzareno Galiè</dc:creator>
<dc:creator>Massimiliano Palazzini</dc:creator>
<dc:creator>Alessandra Manes</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds</dc:title>
<dc:identifier>pmid:37944164</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad672</dc:identifier>
</item>
<item>
<title>Correction to: Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944137/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad714. doi: 10.1093/eurheartj/ehad714. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944137/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944137</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad714>10.1093/eurheartj/ehad714</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944137</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?</dc:title>
<dc:identifier>pmid:37944137</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad714</dc:identifier>
</item>
<item>
<title>4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944136/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: 4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad662. doi: 10.1093/eurheartj/ehad662. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Developing novel therapies to battle the global public health burden of heart failure remains challenging. This study investigates the underlying mechanisms and potential treatment for 4-hydroxynonenal (4-HNE) deleterious effects in heart failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Biochemical, functional, and histochemical measurements were applied to identify 4-HNE adducts in rat and human failing hearts. In vitro studies were performed to validate 4-HNE targets.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: 4-HNE, a reactive aldehyde by-product of mitochondrial dysfunction in heart failure, covalently inhibits Dicer, an RNase III endonuclease essential for microRNA (miRNA) biogenesis. 4-HNE inhibition of Dicer impairs miRNA processing. Mechanistically, 4-HNE binds to recombinant human Dicer through an intermolecular interaction that disrupts both activity and stability of Dicer in a concentration- and time-dependent manner. Dithiothreitol neutralization of 4-HNE or replacing 4-HNE-targeted residues in Dicer prevents 4-HNE inhibition of Dicer in vitro. Interestingly, end-stage human failing hearts from three different heart failure aetiologies display defective 4-HNE clearance, decreased Dicer activity, and miRNA biogenesis impairment. Notably, boosting 4-HNE clearance through pharmacological re-activation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) using Alda-1 or its improved orally bioavailable derivative AD-9308 restores Dicer activity. ALDH2 is a major enzyme responsible for 4-HNE removal. Importantly, this response is accompanied by improved miRNA maturation and cardiac function/remodelling in a pre-clinical model of heart failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: 4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944136/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944136</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad662>10.1093/eurheartj/ehad662</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944136</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Ligia A Kiyuna</dc:creator>
<dc:creator>Darlan S Candido</dc:creator>
<dc:creator>Luiz R G Bechara</dc:creator>
<dc:creator>Itamar C G Jesus</dc:creator>
<dc:creator>Lisley S Ramalho</dc:creator>
<dc:creator>Barbara Krum</dc:creator>
<dc:creator>Ruda P Albuquerque</dc:creator>
<dc:creator>Juliane C Campos</dc:creator>
<dc:creator>Luiz H M Bozi</dc:creator>
<dc:creator>Vanessa O Zambelli</dc:creator>
<dc:creator>Ariane N Alves</dc:creator>
<dc:creator>Nicolás Campolo</dc:creator>
<dc:creator>Mauricio Mastrogiovanni</dc:creator>
<dc:creator>Silvina Bartesaghi</dc:creator>
<dc:creator>Alejandro Leyva</dc:creator>
<dc:creator>Rosario Durán</dc:creator>
<dc:creator>Rafael Radi</dc:creator>
<dc:creator>Guilherme M Arantes</dc:creator>
<dc:creator>Edécio Cunha-Neto</dc:creator>
<dc:creator>Marcelo A Mori</dc:creator>
<dc:creator>Che-Hong Chen</dc:creator>
<dc:creator>Wenjin Yang</dc:creator>
<dc:creator>Daria Mochly-Rosen</dc:creator>
<dc:creator>Ian J MacRae</dc:creator>
<dc:creator>Ludmila R P Ferreira</dc:creator>
<dc:creator>Julio C B Ferreira</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification</dc:title>
<dc:identifier>pmid:37944136</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad662</dc:identifier>
</item>
<item>
<title>Game changer epidemiological studies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944059/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7;44(42):4393-4397. doi: 10.1093/eurheartj/ehad739.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944059/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944059</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad739>10.1093/eurheartj/ehad739</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944059</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Game changer epidemiological studies</dc:title>
<dc:identifier>pmid:37944059</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad739</dc:identifier>
</item>
<item>
<title>Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944038/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad489. doi: 10.1093/eurheartj/ehad489. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944038/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944038</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad489>10.1093/eurheartj/ehad489</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944038</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Heinz-Peter Schultheiss</dc:creator>
<dc:creator>Felicitas Escher</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome</dc:title>
<dc:identifier>pmid:37944038</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad489</dc:identifier>
</item>
<item>
<title>The European Society of Cardiology working group on atherosclerosis and vascular biology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad536. doi: 10.1093/eurheartj/ehad536. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944036</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad536>10.1093/eurheartj/ehad536</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944036</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Esther Lutgens</dc:creator>
<dc:creator>Elena Osto</dc:creator>
<dc:creator>Marie-Luce Bochaton-Piallat</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The European Society of Cardiology working group on atherosclerosis and vascular biology</dc:title>
<dc:identifier>pmid:37944036</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad536</dc:identifier>
</item>
<item>
<title>Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944029/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad665. doi: 10.1093/eurheartj/ehad665. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944029/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37944029</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad665>10.1093/eurheartj/ehad665</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944029</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Wai Hong Wilson Tang</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges</dc:title>
<dc:identifier>pmid:37944029</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad665</dc:identifier>
</item>
<item>
<title>New Way to Study Pulmonary Hypertension in HFpEF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):899-901. doi: 10.1161/CIRCRESAHA.123.323753. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37943948</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323753>10.1161/CIRCRESAHA.123.323753</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943948</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:creator>Edward Benjamin Thorp</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>New Way to Study Pulmonary Hypertension in HFpEF</dc:title>
<dc:identifier>pmid:37943948</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323753</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943946/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):884. doi: 10.1161/RES.0000000000000643. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943946/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37943946</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000643>10.1161/RES.0000000000000643</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943946</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37943946</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000643</dc:identifier>
</item>
<item>
<title>Receptor-Specific Inside-Out cAMP Signaling Regulates Cardiomyocyte Fate</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943945/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):924-926. doi: 10.1161/CIRCRESAHA.123.323754. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943945/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37943945</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323754>10.1161/CIRCRESAHA.123.323754</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943945</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Frank Lezoualc'h</dc:creator>
<dc:creator>Viacheslav O Nikolaev</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Receptor-Specific Inside-Out cAMP Signaling Regulates Cardiomyocyte Fate</dc:title>
<dc:identifier>pmid:37943945</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323754</dc:identifier>
</item>
<item>
<title>2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37942682/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>The International Liaison Committee on Resuscitation engages in a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation and first aid science. Draft Consensus on Science With Treatment Recommendations are posted online throughout the year, and this annual summary provides more concise versions of the final Consensus on Science With Treatment Recommendations from all task forces for the year. Topics addressed by systematic reviews this year include resuscitation of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 9. doi: 10.1161/CIR.0000000000001179. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The International Liaison Committee on Resuscitation engages in a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation and first aid science. Draft Consensus on Science With Treatment Recommendations are posted online throughout the year, and this annual summary provides more concise versions of the final Consensus on Science With Treatment Recommendations from all task forces for the year. Topics addressed by systematic reviews this year include resuscitation of cardiac arrest from drowning, extracorporeal cardiopulmonary resuscitation for adults and children, calcium during cardiac arrest, double sequential defibrillation, neuroprognostication after cardiac arrest for adults and children, maintaining normal temperature after preterm birth, heart rate monitoring methods for diagnostics in neonates, detection of exhaled carbon dioxide in neonates, family presence during resuscitation of adults, and a stepwise approach to resuscitation skills training. Members from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the quality of the evidence, using Grading of Recommendations Assessment, Development, and Evaluation criteria, and their statements include consensus treatment recommendations. Insights into the deliberations of the task forces are provided in the Justification and Evidence-to-Decision Framework Highlights sections. In addition, the task forces list priority knowledge gaps for further research. Additional topics are addressed with scoping reviews and evidence updates.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37942682/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37942682</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001179>10.1161/CIR.0000000000001179</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37942682</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Katherine M Berg</dc:creator>
<dc:creator>Janet E Bray</dc:creator>
<dc:creator>Kee-Chong Ng</dc:creator>
<dc:creator>Helen G Liley</dc:creator>
<dc:creator>Robert Greif</dc:creator>
<dc:creator>Jestin N Carlson</dc:creator>
<dc:creator>Peter T Morley</dc:creator>
<dc:creator>Ian R Drennan</dc:creator>
<dc:creator>Michael Smyth</dc:creator>
<dc:creator>Barnaby R Scholefield</dc:creator>
<dc:creator>Gary M Weiner</dc:creator>
<dc:creator>Adam Cheng</dc:creator>
<dc:creator>Therese Djärv</dc:creator>
<dc:creator>Cristian Abelairas-Gómez</dc:creator>
<dc:creator>Jason Acworth</dc:creator>
<dc:creator>Lars W Andersen</dc:creator>
<dc:creator>Dianne L Atkins</dc:creator>
<dc:creator>David C Berry</dc:creator>
<dc:creator>Farhan Bhanji</dc:creator>
<dc:creator>Joost Bierens</dc:creator>
<dc:creator>Thomaz Bittencourt Couto</dc:creator>
<dc:creator>Vere Borra</dc:creator>
<dc:creator>Bernd W Böttiger</dc:creator>
<dc:creator>Richard N Bradley</dc:creator>
<dc:creator>Jan Breckwoldt</dc:creator>
<dc:creator>Pascal Cassan</dc:creator>
<dc:creator>Wei-Tien Chang</dc:creator>
<dc:creator>Nathan P Charlton</dc:creator>
<dc:creator>Sung Phil Chung</dc:creator>
<dc:creator>Julie Considine</dc:creator>
<dc:creator>Daniela T Costa-Nobre</dc:creator>
<dc:creator>Keith Couper</dc:creator>
<dc:creator>Katie N Dainty</dc:creator>
<dc:creator>Vihara Dassanayake</dc:creator>
<dc:creator>Peter G Davis</dc:creator>
<dc:creator>Jennifer A Dawson</dc:creator>
<dc:creator>Maria Fernanda de Almeida</dc:creator>
<dc:creator>Allan R De Caen</dc:creator>
<dc:creator>Charles D Deakin</dc:creator>
<dc:creator>Bridget Dicker</dc:creator>
<dc:creator>Matthew J Douma</dc:creator>
<dc:creator>Kathryn Eastwood</dc:creator>
<dc:creator>Walid El-Naggar</dc:creator>
<dc:creator>Jorge G Fabres</dc:creator>
<dc:creator>Joe Fawke</dc:creator>
<dc:creator>Nino Fijacko</dc:creator>
<dc:creator>Judith C Finn</dc:creator>
<dc:creator>Gustavo E Flores</dc:creator>
<dc:creator>Elizabeth E Foglia</dc:creator>
<dc:creator>Fredrik Folke</dc:creator>
<dc:creator>Elaine Gilfoyle</dc:creator>
<dc:creator>Craig A Goolsby</dc:creator>
<dc:creator>Asger Granfeldt</dc:creator>
<dc:creator>Anne-Marie Guerguerian</dc:creator>
<dc:creator>Ruth Guinsburg</dc:creator>
<dc:creator>Tetsuo Hatanaka</dc:creator>
<dc:creator>Karen G Hirsch</dc:creator>
<dc:creator>Mathias J Holmberg</dc:creator>
<dc:creator>Shigeharu Hosono</dc:creator>
<dc:creator>Ming-Ju Hsieh</dc:creator>
<dc:creator>Cindy H Hsu</dc:creator>
<dc:creator>Takanari Ikeyama</dc:creator>
<dc:creator>Tetsuya Isayama</dc:creator>
<dc:creator>Nicholas J Johnson</dc:creator>
<dc:creator>Vishal S Kapadia</dc:creator>
<dc:creator>Mandira Daripa Kawakami</dc:creator>
<dc:creator>Han-Suk Kim</dc:creator>
<dc:creator>Monica E Kleinman</dc:creator>
<dc:creator>David A Kloeck</dc:creator>
<dc:creator>Peter Kudenchuk</dc:creator>
<dc:creator>Amy Kule</dc:creator>
<dc:creator>Hiroshi Kurosawa</dc:creator>
<dc:creator>Anthony T Lagina</dc:creator>
<dc:creator>Kasper G Lauridsen</dc:creator>
<dc:creator>Eric J Lavonas</dc:creator>
<dc:creator>Henry C Lee</dc:creator>
<dc:creator>Yiqun Lin</dc:creator>
<dc:creator>Andrew S Lockey</dc:creator>
<dc:creator>Finlay Macneil</dc:creator>
<dc:creator>Ian K Maconochie</dc:creator>
<dc:creator>R John Madar</dc:creator>
<dc:creator>Carolina Malta Hansen</dc:creator>
<dc:creator>Siobhan Masterson</dc:creator>
<dc:creator>Tasuku Matsuyama</dc:creator>
<dc:creator>Christopher J D McKinlay</dc:creator>
<dc:creator>Daniel Meyran</dc:creator>
<dc:creator>Vix Monnelly</dc:creator>
<dc:creator>Vinay Nadkarni</dc:creator>
<dc:creator>Firdose L Nakwa</dc:creator>
<dc:creator>Kevin J Nation</dc:creator>
<dc:creator>Ziad Nehme</dc:creator>
<dc:creator>Michael Nemeth</dc:creator>
<dc:creator>Robert W Neumar</dc:creator>
<dc:creator>Tonia Nicholson</dc:creator>
<dc:creator>Nikolaos Nikolaou</dc:creator>
<dc:creator>Chika Nishiyama</dc:creator>
<dc:creator>Tatsuya Norii</dc:creator>
<dc:creator>Gabrielle A Nuthall</dc:creator>
<dc:creator>Shinchiro Ohshimo</dc:creator>
<dc:creator>Theresa M Olasveengen</dc:creator>
<dc:creator>Yong-Kwang Gene Ong</dc:creator>
<dc:creator>Aaron M Orkin</dc:creator>
<dc:creator>Michael J Parr</dc:creator>
<dc:creator>Catherine Patocka</dc:creator>
<dc:creator>Gavin D Perkins</dc:creator>
<dc:creator>Jeffrey M Perlman</dc:creator>
<dc:creator>Yacov Rabi</dc:creator>
<dc:creator>James Raitt</dc:creator>
<dc:creator>Shalini Ramachandran</dc:creator>
<dc:creator>Viraraghavan V Ramaswamy</dc:creator>
<dc:creator>Tia T Raymond</dc:creator>
<dc:creator>Amelia G Reis</dc:creator>
<dc:creator>Joshua C Reynolds</dc:creator>
<dc:creator>Giuseppe Ristagno</dc:creator>
<dc:creator>Antonio Rodriguez-Nunez</dc:creator>
<dc:creator>Charles C Roehr</dc:creator>
<dc:creator>Mario Rüdiger</dc:creator>
<dc:creator>Tetsuya Sakamoto</dc:creator>
<dc:creator>Claudio Sandroni</dc:creator>
<dc:creator>Taylor L Sawyer</dc:creator>
<dc:creator>Steve M Schexnayder</dc:creator>
<dc:creator>Georg M Schmölzer</dc:creator>
<dc:creator>Sebastian Schnaubelt</dc:creator>
<dc:creator>Federico Semeraro</dc:creator>
<dc:creator>Eunice M Singletary</dc:creator>
<dc:creator>Markus B Skrifvars</dc:creator>
<dc:creator>Christopher M Smith</dc:creator>
<dc:creator>Jasmeet Soar</dc:creator>
<dc:creator>Willem Stassen</dc:creator>
<dc:creator>Takahiro Sugiura</dc:creator>
<dc:creator>Janice A Tijssen</dc:creator>
<dc:creator>Alexis A Topjian</dc:creator>
<dc:creator>Daniele Trevisanuto</dc:creator>
<dc:creator>Christian Vaillancourt</dc:creator>
<dc:creator>Myra H Wyckoff</dc:creator>
<dc:creator>Jonathan P Wyllie</dc:creator>
<dc:creator>Chih-Wei Yang</dc:creator>
<dc:creator>Joyce Yeung</dc:creator>
<dc:creator>Carolyn M Zelop</dc:creator>
<dc:creator>David A Zideman</dc:creator>
<dc:creator>Jerry P Nolan</dc:creator>
<dc:creator>Collaborators</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</dc:title>
<dc:identifier>pmid:37942682</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001179</dc:identifier>
</item>
<item>
<title>Autoantibodies against the chemokine receptor 3 predict cardiovascular risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37941454/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In individuals free of autoimmune disease, anti-CXCR3 aAbs were abundant, related to CV end-organ damage, and predicted all-cause death as well as cardiac morbidity and mortality in conjunction with the acceleration of experimental atherosclerosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 6:ehad666. doi: 10.1093/eurheartj/ehad666. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Chronic inflammation and autoimmunity contribute to cardiovascular (CV) disease. Recently, autoantibodies (aAbs) against the CXC-motif-chemokine receptor 3 (CXCR3), a G protein-coupled receptor with a key role in atherosclerosis, have been identified. The role of anti-CXCR3 aAbs for CV risk and disease is unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Anti-CXCR3 aAbs were quantified by a commercially available enzyme-linked immunosorbent assay in 5000 participants (availability: 97.1%) of the population-based Gutenberg Health Study with extensive clinical phenotyping. Regression analyses were carried out to identify determinants of anti-CXCR3 aAbs and relevance for clinical outcome (i.e. all-cause mortality, cardiac death, heart failure, and major adverse cardiac events comprising incident coronary artery disease, myocardial infarction, and cardiac death). Last, immunization with CXCR3 and passive transfer of aAbs were performed in ApoE(-/-) mice for preclinical validation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The analysis sample included 4195 individuals (48% female, mean age 55.5 ± 11 years) after exclusion of individuals with autoimmune disease, immunomodulatory medication, acute infection, and history of cancer. Independent of age, sex, renal function, and traditional CV risk factors, increasing concentrations of anti-CXCR3 aAbs translated into higher intima-media thickness, left ventricular mass, and N-terminal pro-B-type natriuretic peptide. Adjusted for age and sex, anti-CXCR3 aAbs above the 75th percentile predicted all-cause death [hazard ratio (HR) (95% confidence interval) 1.25 (1.02, 1.52), P = .029], driven by excess cardiac mortality [HR 2.51 (1.21, 5.22), P = .014]. A trend towards a higher risk for major adverse cardiac events [HR 1.42 (1.0, 2.0), P = .05] along with increased risk of incident heart failure [HR per standard deviation increase of anti-CXCR3 aAbs: 1.26 (1.02, 1.56), P = .03] may contribute to this observation. Targeted proteomics revealed a molecular signature of anti-CXCR3 aAbs reflecting immune cell activation and cytokine-cytokine receptor interactions associated with an ongoing T helper cell 1 response. Finally, ApoE(-/-) mice immunized against CXCR3 displayed increased anti-CXCR3 aAbs and exhibited a higher burden of atherosclerosis compared to non-immunized controls, correlating with concentrations of anti-CXCR3 aAbs in the passive transfer model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In individuals free of autoimmune disease, anti-CXCR3 aAbs were abundant, related to CV end-organ damage, and predicted all-cause death as well as cardiac morbidity and mortality in conjunction with the acceleration of experimental atherosclerosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37941454/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37941454</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad666>10.1093/eurheartj/ehad666</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37941454</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Felix S Müller</dc:creator>
<dc:creator>Zouhair Aherrahrou</dc:creator>
<dc:creator>Hanna Grasshoff</dc:creator>
<dc:creator>Marc W Heidorn</dc:creator>
<dc:creator>Jens Y Humrich</dc:creator>
<dc:creator>Laurence Johanson</dc:creator>
<dc:creator>Redouane Aherrahrou</dc:creator>
<dc:creator>Tobias Reinberger</dc:creator>
<dc:creator>Andreas Schulz</dc:creator>
<dc:creator>Vincent Ten Cate</dc:creator>
<dc:creator>Alejandro Pallares Robles</dc:creator>
<dc:creator>Thomas Koeck</dc:creator>
<dc:creator>Steffen Rapp</dc:creator>
<dc:creator>Tanja Lange</dc:creator>
<dc:creator>Lukas Brachaczek</dc:creator>
<dc:creator>Finn Luebber</dc:creator>
<dc:creator>Jeanette Erdmann</dc:creator>
<dc:creator>Harald Heidecke</dc:creator>
<dc:creator>Kai Schulze-Forster</dc:creator>
<dc:creator>Ralf Dechend</dc:creator>
<dc:creator>Karl J Lackner</dc:creator>
<dc:creator>Norbert Pfeiffer</dc:creator>
<dc:creator>Jasmin Ghaemi Kerahrodi</dc:creator>
<dc:creator>Oliver Tüscher</dc:creator>
<dc:creator>Andreas Schwarting</dc:creator>
<dc:creator>Konstantin Strauch</dc:creator>
<dc:creator>Thomas Münzel</dc:creator>
<dc:creator>Jürgen H Prochaska</dc:creator>
<dc:creator>Gabriela Riemekasten</dc:creator>
<dc:creator>Philipp S Wild</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Autoantibodies against the chemokine receptor 3 predict cardiovascular risk</dc:title>
<dc:identifier>pmid:37941454</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad666</dc:identifier>
</item>
<item>
<title>Fulminant myocarditis proven by early biopsy and outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37941449/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Endomyocardial biopsy should be broadly and promptly used in patients admitted to the intensive care unit for clinically suspected fulminant myocarditis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 6:ehad707. doi: 10.1093/eurheartj/ehad707. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: While endomyocardial biopsy (EMB) is recommended in adult patients with fulminant myocarditis, the clinical impact of its timing is still unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Data were collected from 419 adult patients with clinically suspected fulminant myocarditis admitted to intensive care units across 36 tertiary centres in 15 countries worldwide. The diagnosis of myocarditis was histologically proven in 210 (50%) patients, either by EMB (n = 183, 44%) or by autopsy/explanted heart examination (n = 27, 6%), and clinically suspected cardiac magnetic resonance imaging confirmed in 96 (23%) patients. The primary outcome of survival free of heart transplantation (HTx) or left ventricular assist device (LVAD) at 1 year was specifically compared between patients with early EMB (within 2 days after intensive care unit admission, n = 103) and delayed EMB (n = 80). A propensity score-weighted analysis was done to control for confounders.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Median age on admission was 40 (29-52) years, and 322 (77%) patients received temporary mechanical circulatory support. A total of 273 (65%) patients survived without HTx/LVAD. The primary outcome was significantly different between patients with early and delayed EMB (70% vs. 49%, P = .004). After propensity score weighting, the early EMB group still significantly differed from the delayed EMB group in terms of survival free of HTx/LVAD (63% vs. 40%, P = .021). Moreover, early EMB was independently associated with a lower rate of death or HTx/LVAD at 1 year (odds ratio of 0.44; 95% confidence interval: 0.22-0.86; P = .016).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Endomyocardial biopsy should be broadly and promptly used in patients admitted to the intensive care unit for clinically suspected fulminant myocarditis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37941449/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37941449</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad707>10.1093/eurheartj/ehad707</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37941449</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Florent Huang</dc:creator>
<dc:creator>Enrico Ammirati</dc:creator>
<dc:creator>Maharajah Ponnaiah</dc:creator>
<dc:creator>Santiago Montero</dc:creator>
<dc:creator>Victor Raimbault</dc:creator>
<dc:creator>Darryl Abrams</dc:creator>
<dc:creator>Guillaume Lebreton</dc:creator>
<dc:creator>Vincent Pellegrino</dc:creator>
<dc:creator>Joshua Ihle</dc:creator>
<dc:creator>Maurizio Bottiroli</dc:creator>
<dc:creator>Romain Persichini</dc:creator>
<dc:creator>Marisa Isabel Barrionuevo-Sánchez</dc:creator>
<dc:creator>Albert Ariza-Solé</dc:creator>
<dc:creator>Pauline Yeung Ng</dc:creator>
<dc:creator>Simon Wai Ching Sin</dc:creator>
<dc:creator>Raj Ayer</dc:creator>
<dc:creator>Hergen Buscher</dc:creator>
<dc:creator>Slimane Belaid</dc:creator>
<dc:creator>Clément Delmas</dc:creator>
<dc:creator>Rita Ferreira</dc:creator>
<dc:creator>Roberto Roncon Albuquerque</dc:creator>
<dc:creator>Teresa Lόpez-Sobrino</dc:creator>
<dc:creator>Jeroen J H Bunge</dc:creator>
<dc:creator>Christoph Fisser</dc:creator>
<dc:creator>Guillaume Franchineau</dc:creator>
<dc:creator>Jamie McCanny</dc:creator>
<dc:creator>Shinichiro Ohshimo</dc:creator>
<dc:creator>Alessandro Sionis</dc:creator>
<dc:creator>Francisco José Hernández-Pérez</dc:creator>
<dc:creator>Eduardo Barge-Caballero</dc:creator>
<dc:creator>Martin Balik</dc:creator>
<dc:creator>Henrique Muglia</dc:creator>
<dc:creator>Sunghoon Park</dc:creator>
<dc:creator>Dirk W Donker</dc:creator>
<dc:creator>Beatriz Porral</dc:creator>
<dc:creator>Nadia Aïssaoui</dc:creator>
<dc:creator>Armand Mekontso Dessap</dc:creator>
<dc:creator>Virginia Burgos</dc:creator>
<dc:creator>Mathieu Lesouhaitier</dc:creator>
<dc:creator>Justin Fried</dc:creator>
<dc:creator>Jae-Seung Jung</dc:creator>
<dc:creator>Sandra Rosillo</dc:creator>
<dc:creator>Vincent Scherrer</dc:creator>
<dc:creator>Saad Nseir</dc:creator>
<dc:creator>Hadrien Winszewski</dc:creator>
<dc:creator>Pablo Jorge-Pérez</dc:creator>
<dc:creator>Antoine Kimmoun</dc:creator>
<dc:creator>Rodrigo Diaz</dc:creator>
<dc:creator>Alain Combes</dc:creator>
<dc:creator>Matthieu Schmidt</dc:creator>
<dc:creator>FULLMOON Study Group</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Fulminant myocarditis proven by early biopsy and outcomes</dc:title>
<dc:identifier>pmid:37941449</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad707</dc:identifier>
</item>
<item>
<title>Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37941127/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 6:ehad735. doi: 10.1093/eurheartj/ehad735. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37941127/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37941127</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad735>10.1093/eurheartj/ehad735</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37941127</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Daria Kramarenko</dc:creator>
<dc:creator>Roddy Walsh</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications</dc:title>
<dc:identifier>pmid:37941127</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad735</dc:identifier>
</item>
<item>
<title>Five easy pieces only account for a fraction of incident cardiovascular disease and all-cause deaths</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37941126/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 6:ehad731. doi: 10.1093/eurheartj/ehad731. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37941126/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37941126</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad731>10.1093/eurheartj/ehad731</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37941126</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Five easy pieces only account for a fraction of incident cardiovascular disease and all-cause deaths</dc:title>
<dc:identifier>pmid:37941126</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad731</dc:identifier>
</item>
<item>
<title>Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940237/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):e193. doi: 10.1016/j.jacc.2023.09.803.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940237/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940237</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.803>10.1016/j.jacc.2023.09.803</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940237</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Pascal M Burger</dc:creator>
<dc:creator>Frank L J Visseren</dc:creator>
<dc:creator>Jannick A N Dorresteijn</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank</dc:title>
<dc:identifier>pmid:37940237</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.803</dc:identifier>
</item>
<item>
<title>C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940236/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):e191-e192. doi: 10.1016/j.jacc.2023.08.052.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940236</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.052>10.1016/j.jacc.2023.08.052</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940236</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Jakub Morze</dc:creator>
<dc:creator>Andrzej Rynkiewicz</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank</dc:title>
<dc:identifier>pmid:37940236</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.052</dc:identifier>
</item>
<item>
<title>Long-Term Incidence of Atrial Fibrillation in Patients With Autoimmune Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940235/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):1969-1971. doi: 10.1016/j.jacc.2023.09.802.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940235/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940235</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.802>10.1016/j.jacc.2023.09.802</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940235</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Guoli Sun</dc:creator>
<dc:creator>Ole Ahlehoff</dc:creator>
<dc:creator>Emil L Fosbøl</dc:creator>
<dc:creator>Morten Schou</dc:creator>
<dc:creator>Mikkel Faurschou</dc:creator>
<dc:creator>Jesper Hastrup Svendsen</dc:creator>
<dc:creator>Lars Køber</dc:creator>
<dc:creator>Jawad H Butt</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Long-Term Incidence of Atrial Fibrillation in Patients With Autoimmune Disease</dc:title>
<dc:identifier>pmid:37940235</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.802</dc:identifier>
</item>
<item>
<title>Member Engagement Key to Transforming Cardiovascular Care for All</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940234/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):1967-1968. doi: 10.1016/j.jacc.2023.09.820.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940234/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940234</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.820>10.1016/j.jacc.2023.09.820</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940234</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>B Hadley Wilson</dc:creator>
<dc:creator>Cathleen Biga</dc:creator>
<dc:creator>Joseph E Marine</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Member Engagement Key to Transforming Cardiovascular Care for All</dc:title>
<dc:identifier>pmid:37940234</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.820</dc:identifier>
</item>
<item>
<title>Imaging Methods for Evaluation of Chronic Aortic Regurgitation in Adults: JACC State-of-the-Art Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940233/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>A global multidisciplinary workshop was convened to discuss the multimodality diagnostic evaluation of aortic regurgitation (AR). Specifically, the focus was on assessment tools for AR severity and analyzing evolving data on the optimal timing of aortic valve intervention. The key concepts from this expert panel are summarized as: 1) echocardiography is the primary imaging modality for assessment of AR severity; however, when data is incongruent or incomplete, cardiac magnetic resonance may be...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):1953-1966. doi: 10.1016/j.jacc.2023.08.051.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A global multidisciplinary workshop was convened to discuss the multimodality diagnostic evaluation of aortic regurgitation (AR). Specifically, the focus was on assessment tools for AR severity and analyzing evolving data on the optimal timing of aortic valve intervention. The key concepts from this expert panel are summarized as: 1) echocardiography is the primary imaging modality for assessment of AR severity; however, when data is incongruent or incomplete, cardiac magnetic resonance may be helpful; 2) assessment of left ventricular size and function is crucial in determining the timing of intervention; 3) recent evidence suggests current cutpoints for intervention in asymptomatic severe AR patients requires further scrutiny; 4) left ventricular end-systolic volume index has emerged as an additional parameter that has promise in guiding timing of intervention; and 5) the role of additional factors (including global longitudinal strain, regurgitant fraction, and myocardial extracellular volume) is worthy of future investigation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940233/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940233</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.051>10.1016/j.jacc.2023.08.051</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940233</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Lauren S Ranard</dc:creator>
<dc:creator>Robert O Bonow</dc:creator>
<dc:creator>Rick Nishimura</dc:creator>
<dc:creator>Michael J Mack</dc:creator>
<dc:creator>Vinod H Thourani</dc:creator>
<dc:creator>Joseph Bavaria</dc:creator>
<dc:creator>Patrick T O'Gara</dc:creator>
<dc:creator>Jeroen J Bax</dc:creator>
<dc:creator>Philipp Blanke</dc:creator>
<dc:creator>Victoria Delgado</dc:creator>
<dc:creator>Jonathon Leipsic</dc:creator>
<dc:creator>Roberto M Lang</dc:creator>
<dc:creator>Hector I Michelena</dc:creator>
<dc:creator>João L Cavalcante</dc:creator>
<dc:creator>Torsten P Vahl</dc:creator>
<dc:creator>Martin B Leon</dc:creator>
<dc:creator>Vera H Rigolin</dc:creator>
<dc:creator>Heart Valve Collaboratory</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Imaging Methods for Evaluation of Chronic Aortic Regurgitation in Adults: JACC State-of-the-Art Review</dc:title>
<dc:identifier>pmid:37940233</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.051</dc:identifier>
</item>
<item>
<title>A New Hope for Deep Learning-Based Echocardiogram Interpretation: The DROIDs You Were Looking For</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37940232/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231109230959&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 14;82(20):1949-1952. doi: 10.1016/j.jacc.2023.09.799.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37940232/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231109230959&v=2.17.9.post6+86293ac">37940232</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.799>10.1016/j.jacc.2023.09.799</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37940232</guid>
<pubDate>Wed, 08 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Márton Tokodi</dc:creator>
<dc:creator>Attila Kovács</dc:creator>
<dc:date>2023-11-08</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>A New Hope for Deep Learning-Based Echocardiogram Interpretation: The DROIDs You Were Looking For</dc:title>
<dc:identifier>pmid:37940232</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.799</dc:identifier>
</item>





























</channel>
</rss>